What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?

POEMS syndrome is a rare plasma cell dyscrasia. This study compared the responses to and survival of 347 POEMS syndrome patients given three first-line treatment regimens: autologous stem cell transplantation (ASCT, N = 165) and melphalan + dexamethasone (MDex, N = 79), or lenalidomide + dexamethaso...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Hao, Huang, Xu-fei, Gao, Xue-min, Cai, Hao, Zhang, Lu, Feng, Jun, Cao, Xin-xin, Zhou, Dao-bin, Li, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756085/
https://www.ncbi.nlm.nih.gov/pubmed/30700844
http://dx.doi.org/10.1038/s41375-019-0391-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756085/
https://www.ncbi.nlm.nih.gov/pubmed/30700844
http://dx.doi.org/10.1038/s41375-019-0391-2

Ejemplares similares